Luseogliflozin

Names

[ Name ]:
Luseogliflozin

[Synonym ]:
TS-071
Luseogliflozin
Lusefi
(1S)-1,5-Anhydro-1-[5-(4-ethoxybenzyl)-2-methoxy-4-methylphenyl]-1-thio-D-glucitol
D-Glucitol, 1,5-anhydro-1-C-[5-[(4-ethoxyphenyl)methyl]-2-methoxy-4-methylphenyl]-1-thio-, (1S)-
UNII-C596HWF74Z
TS-71
TS 071

Biological Activity

[Description]:

Luseogliflozin (TS 071) is a potent, selective, orally active sodium-dependent glucose cotransporter (SGLT) 2 inhibitor, with an IC50 of 2.26 nM, about 1765-fold selectivity over SGLT1 (IC50, 3990 nM). Luseogliflozin has the protential for treating type 2 diabetes.

[Related Catalog]:

Research Areas >> Metabolic Disease

Signaling Pathways >> Membrane Transporter/Ion Channel >> SGLT

[Target]

SGLT2:2.26 nM (IC50)

SGLT1:3990 nM (IC50)

[In Vitro]

Luseogliflozin (TS-071, 3p) is a potent sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor, with an IC50 of 2.26 nM, about 1765-fold selectivity over SGLT1 (IC50, 3990 nM); Luseogliflozin has the protential for treating type 2 diabetes[1].

[In Vivo]

Luseogliflozin (1 mg/kg, p.o.) exhibits a blood glucose lowering effect, excellent urinary glucose excretion properties, and promising PK profiles in rats and dogs[1].

Chemical & Physical Properties

[ Density]:
1.3±0.1 g/cm3

[ Boiling Point ]:
624.5±55.0 °C at 760 mmHg

[ Melting Point ]:
155.0-157.0℃

[ Molecular Formula ]:
C₂₃H₃₀O₆S

[ Molecular Weight ]:
434.546

[ Flash Point ]:
331.5±31.5 °C

[ Exact Mass ]:
434.176300

[ PSA ]:
124.68000

[ LogP ]:
4.43

[ Vapour Pressure ]:
0.0±1.9 mmHg at 25°C

[ Index of Refraction ]:
1.616

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.